Public Reporting

Organizational Information

ACO Participants ACO Participant In Joint Venture
Abrham Tekola, MD, Inc N
Ali R Tajik, MD, Inc N
Ayman Damen N
Eric Tepper N
Kelly Schultz, LLC Y
Louise Krone N
Mangrove Medical Group Y
Med Center Medical Clinic N
Michael Staszel, Do, PA N
Mohali, Inc N
Sarbjeet S Narwan, MD, Inc N
Seema Afsari N
Sierra Family Medical Clinic, Inc N
Sierra Rose Family Physicians Medical Group N
Te Layne, MD, Inc N
Vijaya L Reddy, MD, Inc N

ACO Governing Body

Member First Name Member Last Name Member Title/Position Member's Voting Power –Expressed as a percentage or number Membership Type - ACO Participant Legal Business Name/DBA, if Applicable
Abraham Tekola, MD Board Member 19% ACO Participant Representative ABRHAM TEKOLA M.D. INC
Jerry Davis Board Member 1% Medicare Beneficiary Representative N/A
Kalpesh Patel Board Member 4% Other N/A
Louise Krone Board Member 19% ACO Participant Representative LOUISE KRONE
Randall Caviness Board Member 19% ACO Participant Representative RANDALL CAVINESS
Tanya Layne MD Board Member 19% ACO Participant Representative TE Layne MD INC
Venu Kondle Chairman 19% Community Stakeholder Representative N/A

Member's voting power may have been rounded to reflect a total voting power of 100 percent


Associated Committees & Committee Leadership

Committee Name Committee Member Name and Position
Beneficiary Committee Dr. Ayman Damen, Chair
Beneficiary Committee Dr. Abraham Tekola, Chair
Finance Committee Kal Patel, Chair
Quality & Clinical Informatics Committee Dr. Venu Kondle, Chair
Utilization Committee Dr. Seema Afsari, Chair

Types of ACO Participants, or Combinations of Participants, That Formed the ACO

  1. ACO professionals in a group practice arrangement
  2. Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

Third Agreement Period

    Performance Year 2025, N/A

Second Agreement Period

    Performance Year 2024, N/A
    Performance Year 2023, $1,634,550.63
    Performance Year 2022, $1,401,081
    Performance Year 2021, $3,983,712.65
    Performance Year 2020, $3,250,230
    Performance Year 2019, $1,778,017

Shared Savings Distribution

    Third Agreement Period
      Performance Year 2025
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
    Second Agreement Period
      Performance Year 2024
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
      Performance Year 2023
    • Proportion invested in infrastructure: 20%
    • Proportion invested in redesigned care processes/resources: 10%
    • Proportion of distribution to ACO participants: 70%

      Performance Year 2022
    • Proportion invested in infrastructure: 20%
    • Proportion invested in redesigned care processes/resources: 10%
    • Proportion of distribution to ACO participants: 70%

      Performance Year 2021
    • Proportion invested in infrastructure: 20%
    • Proportion invested in redesigned care processes/resources: 10%
    • Proportion of distribution to ACO participants: 70%

      Performance Year 2020
    • Proportion invested in infrastructure: 20%
    • Proportion invested in redesigned care processes/resources: 10%
    • Proportion of distribution to ACO participants: 70%

      Performance Year 2019
    • Proportion invested in infrastructure: 20%
    • Proportion invested in redesigned care processes/resources: 10%
    • Proportion of distribution to ACO participants: 70%
Our ACO re-entered the Shared Savings Program in Performance Year 2019-A under agreement period 2. Shared savings/losses and shared savings distributions are therefore reported, beginning with this agreement period.

Quality Performance Results

2023 Quality Performance Results

Quality performance results are based on the CMS Web Interface collection type.

Measure # Measure Name Collection Type Reported Performance Rate Current Year Mean Performance Rate (SSP ACOs) <
110 Preventative Care and Screening: Influenza Immunization CMS Web Interface 67.3 70.76
112 Breast Cancer Screening CMS Web Interface 75.74 80.36
113 Colorectal Cancer Screening CMS Web Interface 84.81 77.14
134 Preventative Care and Screening: Screening for Depression and Follow-up Plan CMS Web Interface 55.75 80.97
226 Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention CMS Web Interface 100.00 79.29
236 Controlling High Blood Pressure CMS Web Interface 81.70 77.80
318 Falls: Screening for Future Fall Risk  CMS Web Interface 85.24 89.42
370 Depression Remission at Twelve Months CMS Web Interface 2.42 16.58
438 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease CMS Web Interface 65.85 87.05
479 Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups CMS Web Interface 0.16 0.16
001 Diabetes:Hemoglobin A1c (HbA1c) Poor Control CMS Web Interface 25.17 9.84

For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov.

Payment Rule Waivers

  • Payment for Telehealth Services:
    • Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613.